Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Glucose Transporters01:27

Glucose Transporters

27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.

Blood advances·2026
Same author

Epicardial Contributions to Fibro-Inflammatory Signaling in a Pkp2-Deficient Arrhythmogenic Cardiomyopathy Model.

Circulation. Heart failure·2026
Same author

Local delivery of SBRT and IL-12 to murine PDAC tumors modulates hematopoiesis.

Oncoimmunology·2026
Same author

All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.

The New England journal of medicine·2026
Same author

IL1β/IL1R1/IRAK4 Drives Inflammatory Ovarian Cancer Seeding at the inflamed sites and Is Reversed by an IRAK4 inhibitor UR241-2.

bioRxiv : the preprint server for biology·2026
Same author

A human synovial tendon-on-a-chip models key features of peritendinous adhesions and offers a new approach methodology for testing anti-fibrotic drugs.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 13, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.8K

Taurine transporter SLC6A6 expression promotes mesenchymal stromal cell function.

Christina M Kaszuba1,2, Benjamin J Rodems2,3, Sonali Sharma2,3

  • 1Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.

Cell Death & Disease
|January 8, 2026
PubMed
Summary
This summary is machine-generated.

Taurine transporter (TauT) is crucial for mesenchymal stromal cell (MSC) function. Loss of TauT impairs MSC osteogenic differentiation, reduces bone strength, and affects stem cell populations, highlighting taurine

More Related Videos

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

1.2K
Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
06:50

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges

Published on: October 4, 2024

1.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.8K
Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
06:58

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles

Published on: October 18, 2024

1.2K
Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
06:50

Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges

Published on: October 4, 2024

1.5K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background:

  • Mesenchymal stromal cells (MSCs) are vital for bone development, repair, and regulating stem cell populations.
  • Taurine transporter (TauT) supports leukemia cell growth, but its role in MSCs is unclear.
  • Taurine supplementation can improve bone defects, yet its direct impact on MSCs is poorly understood.

Purpose of the Study:

  • To investigate the role of taurine transporter (TauT) in mesenchymal stromal cell (MSC) maintenance and osteogenic differentiation.
  • To determine the in vivo and in vitro effects of TauT loss on MSC populations and bone health.
  • To elucidate the molecular mechanisms by which TauT influences MSC function.

Main Methods:

  • Analysis of murine bone marrow single-cell RNA-sequencing data to identify TauT expression in MSCs.
  • Utilizing TauT genetic loss-of-function murine models (knockout mice).
  • In vitro studies involving shRNA-based knockdown of TAUT in human MSCs and co-culture assays with hematopoietic stem and progenitor cells.

Main Results:

  • TauT expression is enriched in murine MSCs.
  • TauT loss in mice impairs MSC populations in vivo and osteogenic differentiation in vitro.
  • TauT deficiency leads to reduced bone mineral density and strength in mice.
  • Knockdown of TAUT in human MSCs reduces osteogenic differentiation.
  • TauT null MSCs exhibit impaired support for hematopoietic stem and progenitor cell self-renewal.
  • TauT loss is linked to downregulated inositol metabolism, increased oxidative stress, and reduced Wnt/β-catenin signaling, promoting MSC senescence.

Conclusions:

  • Taurine transporter (TauT) is essential for maintaining mesenchymal stromal cell (MSC) populations and their osteogenic differentiation.
  • TauT plays a critical role in bone health and stem cell regulation.
  • Taurine is identified as a key regulator of MSC fate determination and maintenance through modulation of metabolic and signaling pathways.